WO2010060624A3 - Trockenverarbeitung und neue formen von lacosamid - Google Patents
Trockenverarbeitung und neue formen von lacosamid Download PDFInfo
- Publication number
- WO2010060624A3 WO2010060624A3 PCT/EP2009/008436 EP2009008436W WO2010060624A3 WO 2010060624 A3 WO2010060624 A3 WO 2010060624A3 EP 2009008436 W EP2009008436 W EP 2009008436W WO 2010060624 A3 WO2010060624 A3 WO 2010060624A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lacosamide
- dry processing
- novel forms
- adhesive agent
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Die Erfindung betrifft Trockenverfahren zur Herstellung von Tabletten enthaltend Lacosamid und Adhäsionsmittel. Ferner betrifft die Erfindung kompaktierte Intermediate enthaltend Lacosamid und ein Adhäsionsmittel sowie eine pharmazeutische Darreichungsform enthaltend Lacosamid in polymorpher Form R, S und/oder T. Ferner werden Verfahren zur Herstellung der polymorphen Formen R, S und T offenbart.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008059155A DE102008059155A1 (de) | 2008-11-27 | 2008-11-27 | Trockenverarbeitung und neue Formen von Lacosamid |
DE102008059155.6 | 2008-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010060624A2 WO2010060624A2 (de) | 2010-06-03 |
WO2010060624A3 true WO2010060624A3 (de) | 2011-05-12 |
Family
ID=41571721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/008436 WO2010060624A2 (de) | 2008-11-27 | 2009-11-26 | Trockenverarbeitung und neue formen von lacosamid |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102008059155A1 (de) |
WO (1) | WO2010060624A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR080275A1 (es) | 2009-08-06 | 2012-03-28 | Medichem Sa | Formas solidas de un derivado de n-( fenilmetil) propanamida y procedimientos de preparacion |
ES2753141T3 (es) | 2009-11-03 | 2020-04-07 | Lupin Ltd | Formulación de liberación modificada de lacosamida |
WO2011061610A2 (en) * | 2009-11-19 | 2011-05-26 | Ranbaxy Laboratories Limited | Processes for preparation of polymorphic forms of lacosamide |
WO2011101863A2 (en) * | 2010-02-19 | 2011-08-25 | Cadila Healthcare Limited | Extended release pharmaceutical compositions of lacosamide |
EP2468261A1 (de) * | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulierung von Lacosamid |
NZ610701A (en) * | 2010-12-02 | 2015-06-26 | Ucb Pharma Gmbh | Once daily formulation of lacosamide |
WO2014180895A1 (en) | 2013-05-08 | 2014-11-13 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical formulations of lacosamide |
PL2801352T3 (pl) * | 2013-05-08 | 2017-12-29 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Ulegające rozpadowi w jamie ustnej formulacje lakozamidu |
JP6902033B2 (ja) | 2015-12-30 | 2021-07-14 | アダマス ファーマシューティカルズ, インコーポレイテッド | 発作−関連障害の処置のための方法および組成物 |
CN111000812B (zh) * | 2020-01-03 | 2021-06-18 | 石药集团中奇制药技术(石家庄)有限公司 | 一种拉考沙胺片的制备方法 |
CN114524746B (zh) * | 2022-01-21 | 2022-11-11 | 河北广祥制药有限公司 | 拉考沙胺晶型的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2218024T3 (es) | 1996-03-15 | 2004-11-16 | Research Corporation Technologies, Inc | Derivados de aminoacido enantiomerico anticonvulsionante. |
EP1642889A1 (de) | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Verbessertes Syntheseschema für Lacosamid |
-
2008
- 2008-11-27 DE DE102008059155A patent/DE102008059155A1/de not_active Withdrawn
-
2009
- 2009-11-26 WO PCT/EP2009/008436 patent/WO2010060624A2/de active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
Non-Patent Citations (1)
Title |
---|
BAUER; FRÖMMING; FÜHRER (EDS): "Pharmazeutische Technologie", 1993, GEORG THIEME VERLAG, Stuttgart, XP002621734 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010060624A2 (de) | 2010-06-03 |
DE102008059155A1 (de) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010060624A3 (de) | Trockenverarbeitung und neue formen von lacosamid | |
WO2006127898A3 (en) | (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use | |
WO2009139817A3 (en) | Crystalline pharmaceutical and methods of preparation and use thereof | |
WO2010069532A8 (en) | Antibodies against human angiopoietin 2 | |
WO2008046581A3 (de) | Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln | |
WO2010115552A8 (en) | Bispecific anti-erbb-3/anti-c-met antibodies | |
WO2009068214A3 (de) | Heteroaryl-substituierte piperidine | |
WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
IL188786A0 (en) | Intermediate compound for synthesizing pharmaceutical agent and production method thereof | |
WO2007132354A3 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
WO2007062370A3 (en) | Calcilytic compounds | |
EP2394993A4 (de) | Neues 2,6-substituiertes 3-nitropyridinderivat, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält | |
WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2007115929A8 (de) | Thiazolyl-dihydro-quinazoline | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
WO2011067236A3 (de) | Raltegravir-polymorphe | |
WO2008092939A3 (en) | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation | |
WO2009111785A3 (en) | Treatment of sepsis with 5-ethyl-1-phenyl-2(1h)-pyridone and novel methods for synthesis | |
MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
WO2008104957A3 (en) | Novel polymorphic forms of milnacipran hydrochloride | |
WO2010119450A3 (en) | An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
WO2008041176A3 (en) | Process for the preparation of form i and form ii of ritonavir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09760497 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09760497 Country of ref document: EP Kind code of ref document: A2 |